Companies
Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.
Regencell Bioscience Holdings Ltd
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
RGCRegency Centers Corp
Regency Centers is the largest shopping center-focused retail REIT. The company's portfolio includes an interest in 405 properties, which includes nearly 55 million square feet of retail space. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 14% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
REGCORegency Silver Corp.
Regency Silver Corp is a Canadian resource company exploring for high grade Silver in Mexico. Regency's flagship project is the high grade Dios Padre Silver Project in Sonora, Mexico. Regency's objective is to maximize shareholder value by acquiring and developing high potential projects for sale and spinout.
RSMXFRegenerative Medical Technology Group Inc.
Meso Numismatics Inc maintains an online store with eBay (www.mesocoins.com) and participates in live auctions with major companies such as Heritage Auctions, Stacks Bowers Auctions, Lyn Knight Auctions, and Sedwick Coins for the sale of its coins, paper currency, bullion, and medals.
RMTGRegenerex Pharma, Inc.
No description
RGPXRegeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.
REGNRegenique Group Ltd
No description
RGGGRegentis Biomaterials Ltd.
Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients. The Company's current efforts are focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue. GelrinC is Regentis' cartilage injury therapeutic based on a unique hydrogel, erodible and resorbable, matrix of polyethylene glycol. The Company's lead product candidate, GelrinC, is a cell-free, off-the-shelf hydrogel that is cured into a temporary implant in the knee for the treatment of painful injuries to articular knee cartilage. GelrinC was approved as a device with a Conformité Européene mark in Europe, (CE mark number 3900600CE02).
RGNTRegenxbio Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).
RGNXRegional Health Properties, Inc
Regional Health Properties, Inc., headquartered in Atlanta, Georgia, is a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care.
RHEPRegional Management Corp.
Regional Management Corp offers an array of secured loan products to customers with limited access to other sources of credit. The company's only reportable segment is the consumer finance. It offers small loans and large installment loans ranging from $500 to $20,000; automobile loans; retail loans secured by the item purchased; and credit insurance products. Small loans, which are for less than $2,500 and fewer than 36 months, account for roughly half of Regional's total loans outstanding and have the highest yields of all its products. The company's principal source of revenue is interest and fee income on outstanding loans.
RMRegions Financial Corp
Regions Financial is a regional bank headquartered in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, insurance, and trust services.
RFRegis Corp
Regis Corporation (NasdaqGM:RGS) is a leader in the haircare industry. As of September 30, 2025, the Company franchised or owned 3,879 locations. Regis' franchised and corporate locations operate under concepts such as Supercuts®, SmartStyle®, Cost Cutters®, Roosters® and First Choice Haircutters®.
RGSRego Payment Architectures, Inc.
Rego Payment Architectures Inc is a technology company focused on delivering an online e-commerce solution for the family. Its system allows parents and their children to manage, allocate funds and track their expenditures, savings, and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use. Geographically all the business activity functions through the region of the United States and it derives revenue in the form of subscription, service fees, transaction fees, and revenue sharing with banking and distribution partners.
RPMTRegulus Therapeutics Inc.
No description
RGLSRein Therapeutics, Inc.
Rein Therapeutics, Inc., formerly Aileron Therapeutics, Inc., is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class therapies to address significant unmet medical needs in orphan pulmonary and fibrosis indications. The Company's lead product candidate, LTI-03 (idiopathic pulmonary fibrosis), is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Its second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions. LTI-01 has received Orphan Drug Designation in the United States and European Union and Fast Track Designation in the United States. Its pipeline also includes LTI-05 (cystic fibrosis).
RNTXReinsurance Group Of America Inc
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
RGAReitar Logtech Holdings Ltd
Reitar Logtech is Asia's first integrated Property+Logistics Technology (PLT) solutions platform. The company focuses on improving the whole life cycle management of logistics assets through technological innovation, providing comprehensive services including investment development, operation management and digital upgrade. Through the integration of smart warehouse systems, IoT devices and data analysis platforms, Reitar is committed to optimizing logistics operation efficiency and achieving efficient resource allocation of the industrial chain.
RITRRekor Systems, Inc.
Rekor Systems Inc is a United States-based company. It is engaged in providing real-time roadway intelligence through AI-driven decisions. Rekor bridges commercial and government sectors with actionable, real-time vehicle recognition data. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. Its machine learning software can turn most IP cameras into accurate vehicle recognition devices used to help protect lives, increase brand loyalty, and enhance operations and logistics. Its geographical segments are the United States, Canada, and Others, of which the majority of its revenue comes from the United States.
REKRRelativity Holdings Inc.
No description
BIOTRelay Therapeutics, Inc.
Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020.
RLAYRelevant Gold Corp.
Relevant Gold Corp. is a North American gold exploration company founded by experienced exploration geologists and operated by a highly respected team with a proven record of significant value creation for shareholders. Relevant Gold is focused on the acquisition, exploration, discovery, and development of district-scale gold projects in the state of Wyoming - one of the most mining-friendly jurisdictions in the United States and globally.
RGCCFReliability Inc
Reliability Inc is a provider of employer of record (EOR) and temporary media and information technology (IT) staffing services. It operates within three industry segments: EOR, Recruiting and Staffing, Video and Multimedia Production, and others. The EOR segment which generates a majority of revenue for the company provides media field talent to a host of large corporate customers.
RLBYReliance Global Group, Inc.
Reliance Global Group, Inc. operates as a holding company with diversified interests in the insurance and real estate markets. The Company is focused on acquiring growing, cash flow positive insurance agencies. Within the real estate segment, the Company is involved in acquiring, owning, leasing, managing, and redeveloping multifamily residential properties throughout the U.S. for risk-adjusted returns.
RELIReliance, Inc.
Reliance, Inc. is a diversified metal solutions provider and has a metals service center company in North America. The Company provides value-added metals processing services and distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, specialty carbon and alloy steel plate and round bar and specialty steel products. It serves various industries, such as general manufacturing, non-residential construction (including infrastructure), transportation (rail, truck trailer and shipbuilding), aerospace (commercial, military, defense, and space, and heavy industry, energy (oil and natural gas). It also services the auto industry, primarily through its toll processing operation. It has a network of approximately 315 locations in 40 states and in 12 foreign countries, including Belgium, Canada, China, France, India, Malaysia, Mexico, Singapore, South Korea, Turkey, the United Arab Emirates and the United Kingdom.
RSRelief Therapeutics Holding Sa
Relief is a commercial-stage biopharmaceutical company dedicated to advancing treatment paradigms and improving the lives of patients with rare and debilitating diseases. With core expertise in drug delivery systems and drug repurposing, Relief's clinical pipeline includes innovative treatments designed to address critical unmet medical needs in rare dermatological, metabolic and respiratory conditions. The Company has also successfully brought several approved products to market through licensing and distribution partnerships.
RLFTFRelmada Therapeutics, Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
RLMDRelx Plc
LexisNexis® Risk Solutions harnesses the power of data, sophisticated analytics platforms and technology solutions to provide insights that help businesses across multiple industries and governmental entities reduce risk and improve decisions to benefit people around the globe. Headquartered in metro Atlanta, Georgia , we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX ), a global provider of information-based analytics and decision tools for professional and business customers. For more information, please visit www.risk.lexisnexis.com , and www.relx.com .
RELXRemark Holdings, Inc.
Remark Holdings Inc delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a range of applications within the retail, financial, public safety, and workplace arenas. The company also owns and operates digital media properties that deliver relevant content and e-commerce solutions. The group operates in one segment namely Technology & Data Intelligence segment which provides products and services to customers based upon the data collected and processed by its proprietary data intelligence software.
MARKRemitly Global, Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
RELY
